New hope for rheumatoid arthritis sufferers: experimental drug ELV001 enters phase 2 trial
Disease control
Recruiting now
This study tests an experimental drug called ELV001 in people with active rheumatoid arthritis who have not gotten enough relief from standard treatments like methotrexate or TNF inhibitors. About 180 to 220 adults will receive either ELV001 or a placebo added to their current me…
Phase: PHASE2 • Sponsor: Elevara Medicines Limited • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC